Thunder and lightning: immunotherapy and oncolytic viruses collide - Wikidata - wikimedia - TriplyDB

Thunder and lightning: immunotherapy and oncolytic viruses collide

Thunder and lightning: immunotherapy and oncolytic viruses collide

http://www.wikidata.org/entity/Q24597894

about

Oncolytic viruses as therapeutic cancer vaccines Oncolytic Viruses: Therapeutics With an Identity Crisis Pancreatic cancer from bench to bedside: molecular pathways and treatment options CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade Viro-immune therapy: A new strategy for treatment of pancreatic cancer Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer Viruses for tumor therapy Sui generis: gene therapy and delivery systems for the treatment of glioblastoma Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates Oncolytic viral therapy for pancreatic cancer: current research and future directions Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer Emerging role of Natural killer cells in oncolytic virotherapy Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells.Viral oncolysis - can insights from measles be transferred to canine distemper virus?Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response.Viruses in cancer treatment.Novel immune checkpoint blocker approved for the treatment of advanced melanoma Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.Kinetics of virus production from single cells Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus.New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity.ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study Curative one-shot systemic virotherapy in murine myeloma.Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo.Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.

P2860

Q21245758-A6B2D2AE-B0FE-4573-AE2A-507F053AEB25 Q26741020-4D0797B8-E12A-435F-95A6-6D57948165E9 Q26747524-B6B9A459-3405-471A-947F-D8F8EF25B343 Q26766798-F3E4AE65-2A06-4A31-82EA-5E8A3F7F57E0 Q26769977-BA567C09-B5FC-44F8-A06E-2680333CA44E Q26774641-F81C5CFE-6D5D-4C81-ACFF-7A87139F93BB Q26775038-5CA366AD-1CB9-4A07-B533-F7FF2DEE7AFC Q26821929-3DF972E9-C7DF-46A6-AC70-18131BFCC434 Q26822694-F6DA43EE-FC12-4899-8459-BD2AFCDF1937 Q26823826-E32BD6F9-505D-4DC8-A3D4-55FD0F5DDFF9 Q26850467-5F649202-70DC-479B-B615-38D2E52A7CA2 Q26996518-3E6A7D65-DAFE-4972-8038-898071444B91 Q27007519-D5489DCB-F5B7-434C-BED7-D4681E50E24C Q27011439-6E87DA8F-1488-4C55-BACE-2BECBAD7331B Q27021839-BF075002-B935-4E79-998B-A60B29EE79A8 Q27025330-858DF567-E64F-406B-9460-E39A33B90F0D Q28070762-32F1B923-4919-4F11-B560-6CB9AB23BFE2 Q33610214-D5872FC6-26C3-4CFA-A228-0CE886C251E5 Q33613549-5C17721F-9113-4672-BA0B-122442755188 Q33820717-F464D0BF-671A-457D-9D59-E1D5E3AF93ED Q33870670-6348D3B9-7733-4396-B505-1F6165776DF6 Q34063551-1C1E72F0-AFEA-4953-9E62-C730063509DC Q34311097-EE83D619-00AC-4BCD-B8CF-E47656FBE329 Q34936394-06BCF4C0-CB2C-4A9E-A09B-49C0E0074EDF Q35224606-46F7CD59-0C2A-49D9-B281-2FFFF712717C Q35506253-4CCF5A40-C4BC-49DF-B162-A0EBDF822289 Q35596563-27D09F39-C82B-450A-A166-21E047A23608 Q35600445-D9EC620F-4B46-4BB9-8C48-87B1397E8C17 Q35713464-C1EB86A2-47EB-4ECC-9360-4097FAAB0F16 Q35785494-6BE508BC-DE85-4A70-8735-8F5EC9938714 Q35824064-3FE332F8-BE53-40A2-A531-9098CB9016E2 Q35864258-76D0280D-906C-42D5-89D5-39ED6EB1323C Q36014043-D8FA3A50-560F-46B7-8F4D-078A5850DBD6 Q36028552-33493161-04F1-4299-9E78-A342F114A8D9 Q36139716-AA621C8C-E928-4EF4-BE3F-767BF9C7A338 Q36220618-5F110009-DFAD-4FFE-BE43-7B9880A3F9E0 Q36220647-A42629C6-FAC1-4E3D-B7A4-FF2A0B02B8E8 Q36308045-92371C78-6A60-42E3-B801-74A083BA6D9A Q36582819-09B2D21D-E6BC-4DB2-8BA4-3C338F64F829 Q36664213-C73CBA60-4534-4973-B8B7-3FDC179EE3AB

P2860

Thunder and lightning: immunotherapy and oncolytic viruses collide

http://www.wikidata.org/entity/Q24597894

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Thunder and lightning: immunotherapy and oncolytic viruses collide

@ast

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en-gb

Thunder and lightning: immunotherapy and oncolytic viruses collide

@nl

type

label

Thunder and lightning: immunotherapy and oncolytic viruses collide

@ast

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en-gb

Thunder and lightning: immunotherapy and oncolytic viruses collide

@nl

prefLabel

Thunder and lightning: immunotherapy and oncolytic viruses collide

@ast

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en-gb

Thunder and lightning: immunotherapy and oncolytic viruses collide

@nl

P1433

Q24597894-D6D30494-27CD-4957-BE00-C75D7673C213

P1476

Q24597894-2783ECEF-86E0-49C3-BA8A-32D924B5E4D3

P2093

Q24597894-8D8FF5C6-A049-405F-92AC-62D5B5684D2E

Q24597894-E99DCED5-522B-4EE7-B105-9E4489906CBF

P2860

Q24597894-01949314-6245-4C59-939B-B787A8B2A4DB

Q24597894-0E00A9E6-80A0-47C5-9E9C-DA0B39EFD91B

Q24597894-131A1E19-4B25-45FA-A8CC-1E4D998C4CA3

Q24597894-16278AE7-0187-419B-9B99-8F0CD325EDE0

Q24597894-1DD64B8E-2CCE-46D7-8CDE-DA761EA7A717

Q24597894-2017DB50-B629-40A4-B32C-B3DBAEE1DE75

Q24597894-257AA1F4-5A7F-4588-94BD-49E8EF602166

Q24597894-2977FEF0-10CA-4FBE-8965-0CB26585E707

Q24597894-2AECD1A1-9B5F-470D-AC1D-F7475F022AA5

Q24597894-2CF1E99D-B734-459F-80BC-DA382693D603

P304

Q24597894-15FA831A-656C-4727-90AD-C136093D9487

P31

Q24597894-1D41219B-4965-424B-9F4B-8A0684ACD267

P3181

Q24597894-5E4E5840-C511-4B71-89AC-C7BE0F301470

P356

Q24597894-18DC2EF4-894C-4F37-A0DE-1D61D1BBE5A3

P407

Q24597894-F59D171E-B9EA-4BD7-BE59-C3C0E2EB6A8A

P433

Q24597894-2BBA79E6-C90B-45F3-8C49-5A18CC1E81D1

P478

Q24597894-06DE7392-6402-4554-8087-2B8B3940BA30

P50

Q24597894-8EF2A16D-FD14-4631-A88C-64C50EEBEA2E

Q24597894-CF59505A-B801-401F-A992-A9044AF22DBE

P577

Q24597894-D5904C3E-5B2C-40E3-A78D-95D622D21968

P5875

Q24597894-56CB3711-05EB-40F2-B896-0ACC2D56A2B0

P698

Q24597894-CE06623E-653D-4F6B-803A-AA1A751C2463

P921

Q24597894-4B8CCC3B-C740-47F5-A7A0-BD95203D9018

Q24597894-C341B783-A3E8-4D19-9375-A5436AB5BC25

Q24597894-F2821055-C944-4C8A-98CC-2B2DD1AAE29B

P932

Q24597894-E464594B-80DB-465D-A17B-17C84F903AB8

P3181

P356

P1433

Molecular Therapy

P1476

Thunder and lightning: immunotherapy and oncolytic viruses collide

@en

P2093

Cliona M Rooney

http://www.w3.org/2001/XMLSchema#string

Kelley Parato

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2

A novel Toll-like receptor that recognizes vesicular stomatitis virus

Potentiating cancer immunotherapy using an oncolytic virus

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

1008-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2561863

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MT.2011.65

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51063049

http://www.w3.org/2001/XMLSchema#string

P698

21505424

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3129809

http://www.w3.org/2001/XMLSchema#string